McIlrath & Eck, LLC
- SEC CIK
- 0001701714
- Latest filing
- May 19, 2026
AMGN holding history
Amgen Inc in every 13F filed by McIlrath & Eck, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AMGN overviewAll 13F holders of AMGNFull Q1 2026 holdings
- Shares (Q1 2026)
- 1,870
- Value
- $657.8K
- % of portfolio
- <0.1%
- Quarters held
- 21
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 1,870 | $657.8K | <0.1% | −26−1.4% | Reduced | Holders |
| Q4 2025 | 1,896 | $620.7K | 0.1% | +1+0.1% | Added | Holders |
| Q3 2025 | 1,895 | $534.7K | 0.1% | −5−0.3% | Reduced | Holders |
| Q2 2025 | 1,900 | $530.4K | 0.1% | +847+80.4% | Added | Holders |
| Q1 2025 | 1,053 | $328.0K | <0.1% | +319+43.5% | Added | Holders |
| Q4 2024 | 734 | $191.4K | <0.1% | −353−32.5% | Reduced | Holders |
| Q3 2024 | 1,087 | $350.2K | <0.1% | +10+0.9% | Added | Holders |
| Q2 2024 | 1,077 | $336.4K | <0.1% | −21−1.9% | Reduced | Holders |
| Q1 2024 | 1,098 | $312.2K | <0.1% | +176+19.1% | Added | Holders |
| Q4 2023 | 922 | $265.5K | <0.1% | −73−7.3% | Reduced | Holders |
| Q3 2023 | 995 | $267.5K | 0.1% | −25−2.5% | Reduced | Holders |
| Q2 2023 | 1,020 | $226.5K | <0.1% | −54−5.0% | Reduced | Holders |
| Q1 2023 | 1,074 | $259.7K | 0.1% | +3+0.3% | Added | Holders |
| Q4 2022 | 1,071 | $281.2K | 0.1% | −110−9.3% | Reduced | Holders |
| Q3 2022 | 1,181 | $266.0K | 0.1% | +1+0.1% | Added | Holders |
| Q2 2022 | 1,180 | $287.0K | 0.1% | −12−1.0% | Reduced | Holders |
| Q1 2022 | 1,192 | $288.0K | 0.1% | +1+0.1% | Added | Holders |
| Q4 2021 | 1,191 | $268.0K | 0.1% | +40+3.5% | Added | Holders |
| Q3 2021 | 1,151 | $245.0K | 0.1% | −139−10.8% | Reduced | Holders |
| Q2 2021 | 1,290 | $314.0K | 0.1% | +234+22.2% | Added | Holders |
| Q1 2021 | 1,056 | $263.0K | 0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.